Widget Image
Re-Imagine Aging With Full Cardiovascular Health, Feeling Capable & Feeling Good
Mon - Fri: 9:00AM - 5:00PM Sat - Sun: Closed
Info@NanoBiotechPharma.com
Title Image

Urobac

Home  /  Urobac
NanoBiotech Pharma - NanobacTX - Nanobiotic

Power To Optimize Health

Urobac is a patented, non-prescription, oral nanobiotic compound shown in published clinical trials to affect Nanobacteria (CNPs), calcification and help improve urological & genital system health.

NanoBiotech Pharma - NanobacTX - Nanobiotic

Powerful Nutraceuticals

Urobac is designed to help support and improve the urogenital system. The general course of treatment is 6-12 continuous months of nightly Urobac (8 capsules/night) followed by a maintenance course of 1-2 capsules per night to maintain benefit.

NanoBiotech Pharma - NanobacTX - Nanobiotic

Keeping You Well

One bottle consists of 240 patented capsules (1 month supply). Continue scrolling down to read the published research…

UROBAC is a patented, non-prescription, oral nanobiotic compound shown in published clinical trials to affect Nanobacteria (CNPs) and help improve urological & genital system health. Urobac is designed to help support and improve the urogenital system. The general course of treatment is 6-12 continuous months of nightly Urobac (8 capsules/night) followed by a maintenance course of 1-2 capsules per night to maintain benefit.

Re-Imagine Aging With Full Urological Health, Feeling Capable & Feeling Good

An Independent Summary of Our Scientific Research & Clinical Studies: Anton Kutikhin, PhD in The International Journal of NanoMedicine “The Role of CNPs in Biology & Medicine” www.ncbi.nlm.nih.gov/pmc/articles/PMC3266001

(Please note that for publishing purposes, our Nanobiotics were referred-to as comET for generic purposes and not our actual tradenames of NanobacTX & Urobac. Scientific publications allow only the use of generic names and not trademarks).

Published Science and Clinical Studies:

1. Shoskes, D., K. Thomas, E. Gomez. Urobac Cleveland Clinic Study. Journal of Urology.173: 474-477. https://sci-hub.cc/10.1097/01.ju.0000150062.60633.b2 https://www.sciencedirect.com/science/article/pii/S0022534705605083 https://www.jurology.com/article/S0022-5347(05)60508-3/fulltext

2. Shoskes D, Wood H, The Role of Nanobacteria in Urologic Disease. World J Urol (2006) 24: 51-54 https://sci-hub.cc/10.1007/s00345-005-0041-3

3. Ciftcioglu, N., R. S. Haddad, D. C. Golden, D. R. Morrison, D. S. McKay. NASA-JSC. A cause of kidney stone formation during space flights: Enhanced growth of nanobacteria in microgravity. Kidney International.67: 483-491.

https://sci-hub.cc/10.1111/j.1523-1755.2005.67105.x

4. Shiekh FA, Khullar M, Singh SK. 2006. Lithogenesis: induction of renal calcifications by nanobacteria. Urological Research.34(1):53-7. Click here to view study

5. J.A., R. Jennings, D. Hamilton, A. Sargsyan, R. Pietryzk, N. iftioglu, P. Stepaniak.,NASA-JSC. Genitourinary Issues during Spaceflight: A Review.Int J Impot Res. 2005 Dec;17 Suppl 1:S64-

6. Goldfarb, D. S. Microorganisms and calcium oxalate stones. Nephron Physiol.98(2):48-54. www.ncbi.nlm.nih.gov

7. Khullar M., S. K. Sharma, S. K. Singh, P. Bajwa, F. A. Sheikh, V. Relan, and M. Sharma. Morphological and immunological characteristics of nanobacteria from human renal stones of a north indian population. Urological Research.32 (3):190-195. Click here to view study

8. Drancourt M., V. Jacomo, H. Lepidi, E. Lechevallier, V. Grisoni, C. Coulange, E. Ragni, C. Alasia, B. Dussol, Y. Berland, D. Raoult. Isolation of Nanobacterium sp. Microorganisms from upper urinary tract stones. J Clin Microbiol.41(1):368-372. www.ncbi.nlm.nih.gov

9. Garcia Cuerpo, E. Nanobacteria and urinary system lithiasis. Arch. Esp. Urol.(Review Spanish).56(2):191-192. www.ncbi.nlm.nih.gov

10. Kajander, E. O., N. Ciftcioglu, K. Aho and E. Garcia-Cuerpo. Characteristics of nanobacteria and their role in stone formation. Urol Res.31 (2): 47-54. Click here to view study

11. Rahman, N. U., M. V. Meng, M. L. Stoller 2003. Infections and urinary stones. Curr Pharm Des.9(12):975-981. www.ncbi.nlm.nih.gov

12. Li, Y., Wen, Y. Yang, Z., Wei, H., Liu, W., Tan, A., Wu, X., Wang, Q., Huang, S., Kajander, E. O., Ciftcioglu, N. Culture and identification of Nanobacteria in bile. Zhonghua Yi Xue Za Zhi.82 (22):1557-60. Click here to view study

13. Sommer, A. P., and E. O. Kajander. Nanobacteria-induced kidney stone formation: novel paradigm based on the fermic model. Crystal Growth & Design.2:563-565. Click here to view study

14. Conte Visus A., F. Grases Freixedas, A. Costa-Bauza, P. Piz Reus. Nanobacteria and kidney stones. Arch Esp Uro. (Spanish).54(9) :855-860. www.ncbi.nlm.nih.gov

15. Kajander, E. O., N. Ciftcioglu, M. A. Miller-Hjelle and J. T. Hjelle. Nanobacteria: pathogens in kidney stones. Current Opinions in Nephrology and Hypertension.10:445-452. Click here to view study

16. Garcia Cuerpo, E., O. Kajander, N. Ciftcioglu, F. Lovaco Castellano, C. Correa, J. Gonzalez, F. Mampaso, F. Liano, E. Garcia de Gabiola, A. Escudero Barrilero. Nanobacteria. An experimental neolithogenesis model. Arch Esp Urol.53(4):291-303. Click here to view study

17. Hjelle, J. T., M. A. Miller-Hjelle, I. R. Poxton, O. Kajander, N. Ciftcioglu, M. L. Jones, R. C. Caughey, R. Brown, P. D. Millikin, F. S. Darras. Endotoxin and nanobacteria. Kidney International.57: 2360-2374. Click here to view study

18. Kramer, G., H. C. Klingler, G. E. Steiner. Nanobacteria in kidney stones. Curr Opin Urol.10(1):35-38. www.ncbi.nlm.nih.gov Lopez-Brea M., R. Selgas.

19. Nanobacteria as a cause of renal and vascular calcifying pathology. Enferm Infec. Microbiol. Cli. (Spanish).18(10):491-492. www.ncbi.nlm.nih.gov

20. Dorrell, S. Nanobacteria linked to kidneys. Molecular Medicine Today. 5(9):373. www.ncbi.nlm.nih.gov

Studies specific to Pathological Calcification & Nanobacteria:

1. Kajander EO. Nanobacteria – Propagating Calcifying Nanoparticles. Lett Appl Microbiol. 2006 Jun; 42(6):549-52. Click here to view study

2. Altundag K, Altundag O, Akyurek S, Atik MA. Association between nanobacteria and malignant microcalcifications. Breast Journal. 2006 May-Jun; 12(3):287. www.ncbi.nlm.nih.gov

3. Tsurumoto T., T. Matsumoto, A. Yonekura, and H. Shindo. 2006. Nanobacteria in Human Arthritic Synovial Fluids. Journal of Proteome Research. ASAP Article 10.1021/pr050450w S1535-3893(05)00450-1 [Web Release April 8, 2006] American Chemical Society pubs.acs.org Click here to view study

4. Ciftioglu, N. Nanobacteria-Discovery of a new form of life. Horizons 2006 March 31: 7-8. www.aiaa-houston.org/newsletter

5. Sommer, A. P., N. C. Wichramasinghe. 2005. Functions and Possible Provenance of Primordial Proteins-Part II: Microorganism Aggregation in Clouds Triggered by Climate Change. Journal of Proteome Research. 4: 180-184. Click here to view study

6. Sommer, A. P., A. M. Pretorius, E. O. Kajander, and U. Oron. 2004. Biomineralization induced by stressed nanobacteria. Crystal Growth & Design. 4 (1): 45-46. Click here to view study

7. Sommer, A. P., N. C. Wichramasinghe. 2005. Functions and Possible Provenance of Primordial Proteins-Part II: Microorganism Aggregation in Clouds Triggered by Climate Change. Journal of Proteome Research. 4: 180-184. Click here to view study

8. Wang, X.J., Liu, W., Yang, Z.L., Wei, H., Wen, Y., Li, Y.G. 2004. The detection of nanobacteria infection in serum of healthy Chinese people. Zhonghua Liu Xing Bing Xue Za Zhi. 25(6): 494-4. Click here to view study

9. Wilk, I., G. Martirosian, K. Z. Mikrobiologii, S. A. Medycznei, Khatowice. 2004. Nanobacteria microbiological characteristic. Postepy Hig Med Dosw (online), 2004; 58: 60-64. Click here to view study

10. Barr S. C., R. A. Linke, D. Janssen, C. L. Guard, M. C. Smith, C. S. Daugherty, J. M. Scarlett. 2003. Detection of biofilms formation and nanobacteria under long-term cell culture conditions in serum samples of cattle, goats, cats and dogs. Am J Vet Res. 64(2):176-182.

11. Miller-Hjelle, M. A., J. T. Hjelle, N. Ciftcioglu and E. O. Kajander. 2003. Nanobacteria: methods for growth and identification of this recently discovered calciferous agent. Rapid Analytical Microbiology. The chemistry and physics of microbial identification. Ed. . Olson. PDA, Bethesda, MD, USA. 297-312. Click here to view study

12. Miller-Hjelle, M. A., S. L. Stobbs, I. R. Poxton, J. T. Hjelle. 2003. Nanobacteria antigen and antibody titres in USA controls compared to UK controls and kidney disease patients. 13th European Congress of Clinical Microbiology & Infectious Diseases. P1663. Click here to view study

13. Sedivy, R., and W. B. Battistutti. 2003. Nanobacteria promote crystallization of psammoma bodies. APMIS III. 951-4. Click here to view study

14. Sommer, A. P., D. S. McKay, N. Ciftcioglu, U. Oron, A. R. Mester, and E. O. Kajander. 2003. Living nanovesicles-chemical and physical survival strategies of primordial biosystems. Perspectives, J. Proteome Res. 2:441-443. Click here to view study

15. Sommer, A. P., U. Oron, A. M. Pretorius, D. S. McKay, N. Ciftcioglu, A. R. Mester, E. O. Kajander and H. T. Whelan. 2003. A preliminary investigation into light-modulated replication of nanobacteria in the heart. J. Clin. Laser Med. Surg. 21 (4): 231-235. Click here to view study

16. Ciftcioglu, N., M. A. Miller-Hjelle. J. T. Hjelle and E. O. Kajander. 2002. Inhibition of nanobacteria as measured by a modified microdilution method. Antimicrob Agents Chemother. 46: 2077-2086. Click here to view study

17. Kajander, E. O., K. Aho and V. Segal. 2002. Apatite biofilm forming agent: nanobacteria as a model system for biomineralization and biological standard for noa, a preliminary study. Proceedings of the 2nd International Conference on Near-Field Optical analysis: Photodynamic Therapy & Photobiology Effects. Houston, Texas. Click here to view study

18. Sommer A. P., H. I. Hassinen, E. O. Kajander. 2002. Light-induced replication of nanobacteria: a preliminary report. J Clin Laser Med Surg.20(5):241-244.www.ncbi.nlm.nih.gov

19.Sommer, A. P., U. Oron, E. O. Kajander and A. R. Mester. 2002. Stressed cells survive better with light. J. Proteome Res.1:475. Click here to view study

20. Breitschwerdt, E. B., Sushama, S., Cannedy, A., Hancock, S. I., Bradley. J. M. 2001. Infection with Bartonella weissii and detection of nanobacterium antigens in a North Carolina beef herd Journal of Clinical Microbiology. 879-882. Click here to view study

21. Vali, H., M. D. McKee, N. Ciftcioglu, S. K. Sears, F. L. Plows, E. Chelvet, P. Ghiasi, E. O. Kajander and R. N. Zare. 2001. Nanoforms: a new type of protein-associated mineralization. Geochim.Cosmochim. Acta. 65:63-74. Click here to view study

22. Ciftcioglu, N. and E. O. Kajander. 2000. Nanobacterial growth factors for nanobacteria Proc. SPIE. 3755: 113-119. Click here to view study

23. Kajander, E. O. and N. Ciftcioglu. 2000. Nanobacteria as extremophiles Proc. SPIE. 3755: 106-112. Click here to view study

24. Vainshtein M. B., E. B. Kudriashova. 2000. About nanobacteria. Mikrobiologiia (Russian). 69(2):163-174. www.ncbi.nlm.nih.gov

25. Abbott, A. 1999. Battle lines drawn between nanobacteria researchers. 1999. Nature. 401 (6749):105. www.ncbi.nlm.nih.gov

26. Ciftcioglu, N. 1999. Microbial presence versus pathogenicity. Pleomorphic microbes in health and disease. Proceedings of the first annual symposium held June 18-19. Edited by: Gitte S. Jensen Ph.D. Holger N.I.S. Inc.; 49-53. Click here to view study

27. Kajander, E. O., M. Bjorklund, N. Ciftcioglu. 1999. Nanobacteria and man. Enigmatic Microorganisms and Life in Extreme Environments. Eds.J. Seckbach, Kluwer (the Netherlands). 195-204. Click here to view study

28. Kajander, E. O. 1999. Nanobacteria in health and disease. Pleomorphic microbes in health and disease. Proceedings of the first annual symposium held June 18-19, 1999. Edited by: Gitte S. Jensen Ph.D. Holger N.I.S. Inc. Hudson, Quebec; 43-48. Click here to view study

29. Kajander, E. O., T. Heinonen, I. Kuronen, K. Luoto and N. Ciftcioglu. 1999. A new problem for sterile filtration; nanobacteria. In Proceedings, WorldPharm. 99, October 26-28, 1999, Philadelphia. Advanstar Communications, Cleveland, OH. Pp. 243-252. Click here to view study

30. Kajander, E. O., T. Heinonen, I. Kuronen, K. Luoto, and N. Ciftcioglu. Nanobacteria, mycoplasma and bacterial l-forms; problems for sterile filtration. 30th R3. Nordic Contamination Control Symposium.Helsinki, Finland. Click here to view study

31. Southam, G., R. Donald. 1999. A structural comparison of bacterial microfossils vs. nanobacteria and nanofossils. Earth-Science Reviews.48 (4): 251-264.

32. Wainwright, M. 1999. Nanobacteria and associated elementary bodies in humans. Microbiology. 145: 2623-2624. Click here to view study

33. Bjorklund, M., N. Ciftcioglu, E. O. Kajander. 1998. Extraordinary survival of nanobacteria under extreme conditions. Proc. SPIE. 3441: 123-129. Click here to view study

34. Carson, D. A. 1998. An infectious origin of extraskeletal calcification. PNAS.95: 7846-7847. Click here to view study

35. Ciftcioglu, N., E. O. Kajander. 1998. Interaction of nanobacteria with cultured mammalian cells. Pathophysiology. 4: 259-270. Click here to view study

36. Ciftcioglu, N., M. Bjorklund, E. O. Kajander. 1998. Stone formation and calcification by nanobacteria in human body. Proc. SPIE.3441: 105-111. Click here to view study

37. Ciftcioglu, N., V. Ciftcioglu, H. Vali, E. Turcott, E. O. Kajander. 1998. Sedimentary rocks in our mouth: dental pulp stones made by nanobacteria.Proc. SPIE. 3441: 130-135. Click here to view study

38. Kajander, E. O., M. Bjorklund and N. Ciftcioglu. 1998. Suggestions from observations on nanobacteria isolated from blood. Size limits of very small microorganisms: proceedings of a workshop, steering group on astrobiology. Click here to view study

39. Bergstrom and EO. Kajander. 1999. Nanobacteria: An infectious cause for kidney stone formation. Kidney International. 56:1893-1898. studies board National Research Council; Washington, D.C. October 22-23. www.ncbi.nlm.nih.gov

40. Kajander, E. O., N. Ciftcioglu, M. Bjorklund. 1998. Mineralization by nanobacteria Proc. SPIE. 3441: 86-94. Click here to view study

41. Kajander, E. O., N. Ciftcioglu. 1998. Nanobacteria: An alternative mechanism for pathogenic intra- and extracellular calcification and stone formation Proc. Natl. Acad. Sci. USA 95: 8274-8279. Click here to view study

42. Akerman, K. K., J. T. Kuikka, N. Ciftcioglu, J. Parkkinen, K. A. Bergstrom, I. Kuronen, and E. O. Kajander. 1997. Radiolabeling and in vivo distribution of nanobacteria in rabbit. Proc. SPIE. 3111: 436-442. Click here to view study

43. Ciftcioglu, N., A. Pelttari, E. O. Kajander. 1997. Extraordinary growth phases of nanobacteria isolated from mammalian blood. Proc. SPIE. 3111: 429-435. Click here to view study

44. Cifcioglu, N., I. Kuronen, K. Akerman, E. Hiltunen, J. Laukkanen, E.O. Kajander. 1997. A new potential threat in antigen and antibody products: nanobacteria. Cold spring harbor laboratory. Vaccines 97. 99-103. Click here to view study

45. Kajander, E. O., I. Kuronen; K. Akerman, A. Pelttari, N. Ciftcioglu. 1997. Nanobacteria from blood, the smallest culturable autonomously replicating agent on earth. Proc. SPIE. 3111: 420-428. Click here to view study

46. Kajander, E. O., E. Tahvanainen, I. Kuronen, N. Ciftcioglu. 1994. Comparison of staphylococci and novel bacteria-like particles from blood. Zbl. Bakt. (Suppl.) 26: 147-149. Click here to view study

47. Akerman, K. K., I. Kuronen, and E. O. Kajander. 1993. Scanning electron microscopy of nanobacteria-novel biofilm producing organisms in blood. Scanning. 15 (Suppl.) 3:90-91. Click here to view study

Re-Imagine Aging With Full Urological Health, Feeling Capable & Feeling Good